Cargando…

MITF Modulates Therapeutic Resistance through EGFR Signaling

Response to targeted therapies varies significantly despite shared oncogenic mutations. Nowhere is this more apparent than in BRAF(V600E)-mutated melanomas where initial drug response can be striking and yet relapse is commonplace. Resistance to BRAF inhibitors have been attributed to the activation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Zhenyu, Chen, Yiyin Erin, Kumar, Raj, Taylor, Michael, Njauw, Ching-Ni Jenny, Miao, Benchun, Frederick, Dennie T., Wargo, Jennifer A., Flaherty, Keith T., Jönsson, Göran, Tsao, Hensin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466007/ https://www.ncbi.nlm.nih.gov/pubmed/25789707 http://dx.doi.org/10.1038/jid.2015.105

Ejemplares similares

BAP1 PLAYS A SURVIVAL ROLE IN CUTANEOUS MELANOMA
por: Kumar, Raj, et al.
Publicado: (2014)

Cancer risks associated with the germline MITF(E318K) variant
por: Guhan, Samantha M., et al.
Publicado: (2020)

Growth suppression by dual BRAF(V600E) and NRAS(Q61) oncogene expression is mediated by SPRY4 in melanoma
por: Kumar, Raj, et al.
Publicado: (2019)

Epha2 is a Critical Oncogene in Melanoma
por: Udayakumar, Durga, et al.
Publicado: (2011)

A PAX3/BRN2 rheostat controls the dynamics of BRAF mediated MITF regulation in MITF(high)/AXL(low) melanoma
por: Smith, Michael P., et al.
Publicado: (2018)

Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families
por: Njauw, Ching-Ni Jenny, et al.
Publicado: (2012)

Selective uveal melanoma inhibition with calcium channel blockade
por: SHAUGHNESSY, MICHAEL, et al.
Publicado: (2019)

DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype
por: Sanna, Adriana, et al.
Publicado: (2022)

Subcellular localization of Mitf in monocytic cells
por: Lu, Ssu-Yi, et al.
Publicado: (2010)

Pathway signatures derived from on-treatment tumor specimens predict response to anti-PD1 blockade in metastatic melanoma
por: Du, Kuang, et al.
Publicado: (2021)

A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma
por: Yokoyama, Satoru, et al.
Publicado: (2011)

Combining checkpoint inhibitors and BRAF-targeted agents against metastatic melanoma
por: Cooper, Zachary A., et al.
Publicado: (2013)

MITF links maturation and quiescence
por: LeBrasseur, Nicole
Publicado: (2005)

MITF—the first 25 years
por: Goding, Colin R., et al.
Publicado: (2019)

Targeting MITF in the tolerance-phase
por: Arozarena, Imanol, et al.
Publicado: (2016)

The MITF regulatory network in melanoma
por: Chauhan, Jagat S., et al.
Publicado: (2022)

CDKN2A/CDK4 Status in Greek Patients with Familial Melanoma and Association with Clinico-epidemiological Parameters
por: KARAGIANNI, Fani, et al.
Publicado: (2018)

The RAS/mitogen activated protein (MAP) kinase pathway in melanoma biology and therapeutics
por: Jarell, Abel D, et al.
Publicado: (2007)

BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes
por: Cooper, Zachary A, et al.
Publicado: (2013)

A melanocyte lineage program confers resistance to MAP kinase pathway inhibition
por: Johannessen, Cory M., et al.
Publicado: (2013)

Moderate- to low-risk variant alleles of cutaneous malignancies and nevi: lessons from genome-wide association studies
por: Udayakumar, Durga, et al.
Publicado: (2009)

Effect of the COVID-19 Pandemic on Delayed Skin Cancer Services
por: Rashid, Sarem, et al.
Publicado: (2021)

Mitf Induction by RANKL Is Critical for Osteoclastogenesis
por: Lu, Ssu-Yi, et al.
Publicado: (2010)

A Conditional Zebrafish MITF Mutation Reveals MITF Levels Are Critical for Melanoma Promotion vs. Regression In Vivo
por: Lister, James A, et al.
Publicado: (2014)

Parthenolide induces MITF-M downregulation and senescence in patient-derived MITF-M(high) melanoma cell populations
por: Hartman, Mariusz L., et al.
Publicado: (2016)

Partial Rescue of Ocular Pigment Cells and Structure by Inducible Ectopic Expression of Mitf-M in MITF-Deficient Mice
por: Michael, Helen T., et al.
Publicado: (2018)

Overexpression of Mcl-1 confers resistance to BRAF(V600E) inhibitors alone and in combination with MEK1/2 inhibitors in melanoma
por: Fofaria, Neel M., et al.
Publicado: (2015)

Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours
por: Howlin, Jillian, et al.
Publicado: (2015)

Targeted therapies in melanoma: Translational research at its finest
por: Ho, Allen W., et al.
Publicado: (2015)

Differential Evolution of Duplicated Medakafish mitf Genes
por: Li, Mingyou, et al.
Publicado: (2013)

Meningeal Melanocytes in the Mouse: Distribution and Dependence on Mitf
por: Gudjohnsen, Stefán A. H., et al.
Publicado: (2015)

MITF and TFEB cross-regulation in melanoma cells
por: Ballesteros-Álvarez, Josué, et al.
Publicado: (2020)

Endolysosomal Cation Channels and MITF in Melanocytes and Melanoma
por: Abrahamian, Carla, et al.
Publicado: (2021)

MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment
por: Riesenberg, Stefanie, et al.
Publicado: (2015)

Acquired brachial cutaneous dyschromatosis
por: Everdell, Emily, et al.
Publicado: (2023)

PDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation
por: Sabbatino, Francesco, et al.
Publicado: (2014)

miR-148 Regulates Mitf in Melanoma Cells
por: Haflidadóttir, Benedikta S., et al.
Publicado: (2010)

MITF in melanoma: mechanisms behind its expression and activity
por: Hartman, Mariusz L., et al.
Publicado: (2014)

MITF – A controls branching morphogenesis and nephron endowment
por: Phelep, Aurélie, et al.
Publicado: (2017)

SOX10-MITF pathway activity in melanoma cells
por: Tudrej, Karol B, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_r5ivp2lb4g47ppa8db4soc6l85